Press release
Chemotherapy-Induced Nausea and Vomiting (CINV) Market to Reach USD 4.02 Billion by 2034
Chemotherapy-Induced Nausea and Vomiting
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72895
Growing global cancer prevalence, increasing adoption of highly emetogenic chemotherapy regimens, and the development of next-generation serotonin (5-HT3), neurokinin-1 (NK1) receptor antagonists based therapies are key factors driving market growth.
In 2024, the global CINV market is valued at USD 2.54 billion and is projected to reach USD 4.02 billion by 2034, growing at a CAGR of 4.7%.
Market Overview
• Market Size 2024: USD 2.54 billion
• Forecast 2034: USD 4.02 billion
• CAGR (2025-2034): 4.7%
Key Drivers
• Rising global incidence of cancer and chemotherapy usage.
• Strong demand for combination therapies improving efficacy.
• Increasing use of NK1 receptor antagonists and serotonin receptor antagonists.
• Advances in supportive oncology care and patient quality of life focus.
• Expansion of oncology drug pipelines in emerging markets.
Key Challenges
• High cost of branded anti-emetics.
• Limited access in low- and middle-income countries.
• Generic erosion of established therapies.
• Patient variability in treatment response.
Leading Players
Helsinn Healthcare, Merck & Co., GlaxoSmithKline, Roche Holding AG, Heron Therapeutics, Eisai Co. Ltd., Tesaro (GSK), Kyowa Kirin, and Dr. Reddy's Laboratories.
Segmentation Analysis
By Drug Class
• Serotonin (5-HT3) Receptor Antagonists
• Neurokinin-1 (NK1) Receptor Antagonists
• Dopamine Antagonists
• Corticosteroids
• Combination Therapies
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End User
• Cancer Treatment Centers
• Hospitals
• Specialty Clinics
• Homecare
Summary:
Combination therapies dominate due to their ability to manage acute and delayed CINV more effectively. NK1 receptor antagonists are also gaining traction, particularly in high-emetogenic chemotherapy regimens.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72895/chemotherapy-induced-nausea-and-vomiting-market
Regional Analysis
• North America
The largest market, driven by advanced oncology infrastructure, high cancer prevalence, and strong adoption of innovative therapies.
• Europe
Significant demand for anti-emetics, supported by government healthcare programs and increasing oncology care spending.
• Asia-Pacific
Fastest-growing market due to rising cancer incidence, expanding healthcare access in China and India, and government focus on oncology care.
• Middle East & Africa
Moderate growth, with demand driven by cancer treatment centers in GCC countries and South Africa.
• Latin America
Brazil and Mexico lead adoption due to expanding oncology treatment facilities and improved patient access to supportive therapies.
Summary:
North America and Europe dominate due to advanced oncology infrastructure, while Asia-Pacific is expected to see the fastest growth with expanding access to cancer care and drug availability.
Market Dynamics
Growth Drivers
1. Increasing global cancer burden requiring supportive oncology therapies.
2. Development of next-generation NK1 and 5-HT3 receptor antagonists.
3. Growth in combination therapies for better treatment outcomes.
4. Increasing healthcare expenditure in emerging economies.
5. Rising emphasis on patient-centric cancer care.
Challenges
• High cost and limited reimbursement in some regions.
• Patent expirations and generic competition.
• Unequal access to advanced therapies in low-resource settings.
• Side effects and patient compliance issues.
Latest Trends
• Development of oral fixed-dose combination drugs for convenience.
• Use of therapies for refractory CINV.
• Clinical trials focusing on precision oncology supportive care.
• Increasing role of biosimilars in reducing therapy costs.
• Partnerships between pharma companies and oncology centers for patient support programs.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72895
Competitor Analysis
Key Players
• Helsinn Healthcare
• Merck & Co.
• GlaxoSmithKline
• Roche Holding AG
• Heron Therapeutics
• Eisai Co. Ltd.
• Tesaro (GSK)
• Kyowa Kirin
• Dr. Reddy's Laboratories
Competitive Landscape
The CINV market is moderately consolidated, with Helsinn and Merck leading in NK1 receptor antagonists, while Roche and GSK focus on combination therapies. Generic drugmakers are increasing their market share by offering cost-effective alternatives, especially in Asia-Pacific and Latin America.
Conclusion
The CINV market plays a critical role in improving cancer treatment adherence and patient quality of life. Valued at USD 2.54 billion in 2024, the market is projected to reach USD 4.02 billion by 2034, growing at a CAGR of 4.7%.
Future opportunities lie in oral combination therapies and biosimilars. Companies that focus on innovation, affordability, and patient accessibility will remain leaders in this essential supportive oncology segment.
This report is also available in the following languages : Japanese (化学療法誘発性の吐き気と嘔吐), Korean (화학 요법으로 인한 메스꺼움 및 구토), Chinese (化疗引起的恶心和呕吐), French (Nausées et vomissements induits par la chimiothérapie), German (Durch Chemotherapie verursachte Übelkeit und Erbrechen), and Italian (Nausea e vomito indotti dalla chemioterapia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72895/chemotherapy-induced-nausea-and-vomiting-market#request-a-sample
Our More Reports:
Piston Grouting Pump Market
https://exactitudeconsultancy.com/reports/75246/piston-grouting-pump-market
Complex Coconut Sugar Market
https://exactitudeconsultancy.com/reports/75247/complex-coconut-sugar-market
Telepharmacy Service Market
https://exactitudeconsultancy.com/reports/75248/telepharmacy-service-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy-Induced Nausea and Vomiting (CINV) Market to Reach USD 4.02 Billion by 2034 here
News-ID: 4207266 • Views: …
More Releases from Exactitude Consultancy
Growing demand for home hygiene will propel the smart mite removal vacuum cleane …
Smart mite removal vacuum cleaners are innovative cleaning devices designed to eliminate dust mites, allergens, bacteria, and fine particles from surfaces such as mattresses, upholstery, carpets, and fabrics. Equipped with UV sterilization, HEPA filtration, ultrasonic technology, and smart IoT connectivity, these devices are gaining popularity in households and healthcare environments.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/75203
The surge in allergy-related illnesses, asthma cases, and rising awareness of indoor…
Fill-Finish Pharmaceutical Contract Manufacturing Market to Double, Reaching USD …
The fill-finish pharmaceutical contract manufacturing market plays a vital role in the biopharmaceutical industry, providing specialized services for the final formulation, filling, and packaging of drugs into vials, syringes, and cartridges. This stage is critical to ensure sterility, stability, and compliance with regulatory standards.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72893
With the growth of biologics, vaccines, biosimilars, and cell & gene therapies, demand for contract manufacturing in…
Anticipated that the market for Pyruvate Kinase Deficiency Disorder would surpas …
Pyruvate kinase deficiency (PKD) is a rare inherited metabolic disorder that causes chronic hemolytic anemia due to a deficiency in the pyruvate kinase enzyme, critical for red blood cell energy production. Patients often experience fatigue, jaundice, gallstones, and an enlarged spleen, with disease severity ranging from mild to life-threatening.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72899
While supportive treatments such as blood transfusions, splenectomy, and iron chelation therapy remain…
Single-Cell Sequencing Market is expected to reach USD 15.8 billion by 2034, qua …
Single-cell sequencing (SCS) is transforming biomedical research by enabling high-resolution genetic and transcriptomic analysis at the cellular level. Unlike bulk sequencing, which averages signals across large cell populations, SCS allows researchers to study cellular heterogeneity, rare cell types, and disease mechanisms in unprecedented detail.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72897
The technology has become critical in cancer research, immunology, neurology, stem cell biology, and drug discovery. Its ability…
More Releases for CINV
Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo …
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034?
There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)…
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 …
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market?
The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which would…
Advancements and Trends in the Global Chemotherapy-induced Nausea and Vomiting ( …
Introduction:
The realm of cancer treatment is a dynamic arena where advancements continuously unfold. Among the multitude of challenges that cancer patients face, chemotherapy-induced nausea and vomiting (CINV) is a formidable adversary. In this article, we delve into the intricate landscape of the CINV market, exploring its evolution, current state, and future prospects.
Understanding CINV:
CINV, an acronym that echoes the discomfort experienced by countless individuals, stands for chemotherapy-induced nausea and vomiting. This…
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the…
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that…
Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Research Re …
This report studies Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
GlaxoSmithKline Plc
Helsinn Group
Heron Therapeutics
Merck & Co Inc
Tesaro
...
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of…
